S5 Ep24: The Sunday Roast featuring Eric Leire, CEO of Genflow Biosciences (LSE:GENF) #GENF #CGNR #STAR #CHLL #TM1 #TGR #BRES #SVML #MKA #JLP #HARL #RR.

Phil Carroll and Kevin Hornsby talk to Eric about the SIRT6 gene therapy. The company is developing therapies that deliver a variant of the sirtuin 6 (SIRT6) gene found in centenarians. Genflow already has a pipeline of compounds for human indications including idiopathic pulmonary fibrosis (IPF) and Werner’s syndrome, as well as for targeting aging in dogs. As usual there is a weekly round up of the movers and shakers and a look at the biggest news stories of the past weekDisclaimer & Declaration of InterestThe information, investment views, and recommendations in this podcast are provided for general information purposes only. Nothing in this podcast should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.